Yasmin, HasinaPinkey, Monika Tabassum2022-09-212022-09-2120222022-03ID 18146038http://hdl.handle.net/10361/17249Cataloged from PDF version of thesis report.Includes bibliographical references (pages 45-52).This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.Skin diseases, including inflammatory and infections, result from disruptions in the skin's barrier. Antimicrobial peptides (AMPs) have recently gained attention as potential treatments for inflammatory, soft skin tissue and wound infections. This review discusses AMPs in skin diseases. It highlights the therapeutic properties of AMPs and their potential utility in treating skin disorders. Even though only a few AMPs, such as oritavancin and daptomycin, have been approved for use in clinical trials. Moreover, omiganan, pexiganan, and DPK-060 have also been studied extensively for treating skin problems. This paper also mentions some strategies to increase AMPs' clinical trial success rate.52 pagesenBrac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission.Skin diseasesinflammatory diseaseSoft skin tissue infectionsAntimicrobial peptidesTherapeutic agentsSkin--DiseasesPeptide antibioticsThesis